Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
Morrissey, Kari M., Marchand, Mathilde, Patel, Hina, Zhang, Rong, Wu, Benjamin, Phyllis Chan, H., Mecke, Almut, Girish, Sandhya, Jin, Jin Y., Winter, Helen R., Bruno, RenéJournal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03954-8
Date:
September, 2019
File:
PDF, 989 KB
2019
File converter
More search results
More benefits 
